★ WIDE MOAT STOCKS COMPARISON ★

Checking

Stock Comparison

Medtronic plc vs Zimmer Biomet Holdings, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Medtronic plc

MDT · New York Stock Exchange

Market cap (USD)$119.5B
Gross margin (TTM)65%
Operating margin (TTM)17.8%
Net margin (TTM)13.2%
SectorHealthcare
IndustryMedical - Devices
CountryIE
Data as of2026-08-23
Moat score
71/ 100

Partial score covering 76% of segment weight.

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Medtronic plc's moat claims, evidence, and risks.

View MDT analysis

Zimmer Biomet Holdings, Inc.

ZBH · New York Stock Exchange

Market cap (USD)$19.5B
Gross margin (TTM)69.9%
Operating margin (TTM)15.7%
Net margin (TTM)9.5%
SectorHealthcare
IndustryMedical - Devices
CountryUS
Data as of2026-08-23
Moat score
52/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Zimmer Biomet Holdings, Inc.'s moat claims, evidence, and risks.

View ZBH analysis

Comparison highlights

  • Segment focus: Medtronic plc has 4 segments (38.6% in Cardiovascular Portfolio); Zimmer Biomet Holdings, Inc. has 4 segments (38.1% in Knees).
  • Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Weak.
  • Moat breadth: Medtronic plc has 4 moat types across 2 domains; Zimmer Biomet Holdings, Inc. has 2 across 2.

Primary market context

Medtronic plc

Cardiovascular Portfolio

Market

Cardiovascular medical devices (cardiac rhythm management, electrophysiology/ablation, structural heart, coronary & peripheral vascular)

Geography

Global

Customer

Hospitals, cath labs, electrophysiologists, cardiologists, cardiac & vascular surgeons

Role

Device OEM + procedure support + remote monitoring software/services

Revenue share

38.6%

Zimmer Biomet Holdings, Inc.

Knees

Market

Knee reconstruction implants (primary, partial, revision) plus associated instruments and orthopedic robotics/navigation

Geography

Global

Customer

Hospitals and ambulatory surgery centers

Role

OEM manufacturer

Revenue share

38.1%

Side-by-side metrics

Medtronic plc
Zimmer Biomet Holdings, Inc.
Ticker / Exchange
MDT - New York Stock Exchange
ZBH - New York Stock Exchange
Market cap (USD)
$119.5B
$19.5B
Gross margin (TTM)
65%
69.9%
Operating margin (TTM)
17.8%
15.7%
Net margin (TTM)
13.2%
9.5%
Sector
Healthcare
Healthcare
Industry
Medical - Devices
Medical - Devices
HQ country
IE
US
Primary segment
Cardiovascular Portfolio
Knees
Market structure
Oligopoly
Oligopoly
Market share
n/a
30.1% (reported)
HHI estimate
n/a
n/a
Pricing power
Moderate
Weak
Moat score
71 / 100 (partial, 76% coverage)
52 / 100
Moat domains
Demand, Network
Demand, Supply
Last update
2026-08-23
2026-08-23

Moat coverage

Shared moat types

Design In Qualification

Medtronic plc strengths

Data Workflow LockinEcosystem ComplementsInstalled Base Consumables

Zimmer Biomet Holdings, Inc. strengths

Service Field Network

Segment mix

Medtronic plc segments

Full profile >

Cardiovascular Portfolio

Oligopoly

38.6%

Neuroscience Portfolio

Oligopoly

28.4%

Medical Surgical Portfolio

Competitive

24.4%

MiniMed / Diabetes (consolidated all other)

Oligopoly

8.6%

Zimmer Biomet Holdings, Inc. segments

Full profile >

Knees

Oligopoly

38.1%

Hips

Oligopoly

25.8%

S.E.T. (Sports Medicine, Extremities, Trauma, CMFT)

Competitive

26.9%

Technology & Data, Bone Cement and Surgical

Oligopoly

9.2%

Act on this comparison

Turn a two-stock debate into a systemSee the systematic rankings that surface stocks like MDT and ZBH, with backtests and current holdings.

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.